Senores Pharmaceuticals IPO
Senores Pharmaceuticals Limited (SENORES) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 30 December 2024.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +67.1% (likely range +33% to +119%), day's high +72.0%, chance of a gain 92%. Actual: +53.5% at the open, +55.9% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 45,93,216 | 43,47,78,102 | 94.7x | |
| NII (HNI) total | 23,19,879 | 22,33,98,732 | 96.3x | |
| Big NII (above ₹10 lakh) | 15,46,586 | 14,46,53,764 | 93.5x | |
| Small NII (₹2-10 lakh) | 7,73,293 | 7,87,44,968 | 102x | |
| Retail | 15,46,586 | 13,99,04,334 | 90.5x | |
| Employees | 75,000 | 15,15,478 | 20.2x | |
| Total | 85,34,681 | 79,95,96,646 | 93.7x |
Bids on NSE and BSE together, as published by NSE, as of 24 Dec 2024, 07:00 PM. Shares offered exclude the anchor portion. 16% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Senores Pharmaceuticals's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| Ideaforge TechnologyJun 2023 | 126x | 80.6x | 85.2x | 106x | ₹567 Cr | +93.5% | +100.0% |
| Utkarsh Small Finance BankJul 2023 | 125x | 81.6x | 72.1x | 102x | ₹543 Cr | +60.0% | +92.0% |
| One MobiKwik SystemsDec 2024 | 120x | 109x | 135x | 119x | ₹602 Cr | +57.7% | +89.2% |
| Le Travenues TechnologyJun 2024 | 107x | 111x | 54.8x | 98.3x | ₹740 Cr | +48.5% | +78.2% |
| DOMS IndustriesDec 2023 | 116x | 66.5x | 69.7x | 93.5x | ₹1,265 Cr | +77.2% | +81.5% |
| Awfis Space SolutionsMay 2024 | 117x | 130x | 54.6x | 109x | ₹599 Cr | +13.6% | +17.9% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| Equirus Capital | 34 | +21.3% | 74% |
| Ambit | 13 | +24.3% | 69% |
| Nuvama Wealth Management | 35 | +11.9% | 66% |
Offer documents (NSE)
Frequently asked
What is the Senores Pharmaceuticals IPO price band and lot size? ₹372–391 per share, with a lot of 38 shares, so the smallest retail bid is ₹14,858.
How many times has it been subscribed? 93.7x overall: QIB 94.7x, NII 96.3x, retail 90.5x, employees 20.2x.
How did it list? It opened at ₹600, +53.5% against the issue price of ₹391, and closed its first day +42.5%.
